Pune, India, 13th December 2017: WiseGuyReports announced addition of new report, titled “Global Malaria Vaccine Market Outlook 2024: Global Opportunity and Demand Analysis, Market Forecast, 2016-2024”.
As per WHO, nearly 50% of the global population is at the risk of malaria, there were 214 million malaria cases reported in 2015. In 2012, more than 24 active malaria vaccine candidates were in clinical development and more than 12 were in preclinical development where majority of the candidate targeted Plasmodium falciparum and blood & pre-erythrocytic stages of malaria.
The WHO has introduced a Global Technical Strategy for Malaria 2016-2030 (GTS) in 2015 with specific goals, one of them is focused at eliminating malaria from at least 10 countries. Indian government has introduced Drug Distribution Centers (DDCs) and Fever Treatment Depots (FTDs) in the rural areas for providing easy access to anti-malarial medicines. Many government initiatives like in 2016 GSK announced plans to develop vaccine at profit margin of 5% of the cost of vaccine.
Key Market Players
- Sanaria Inc
o Business Strategy
o Product Portfolio
o SWOT Analysis
- Nobelpharma Co.
- Sumaya Biotech
- GenVec Inc.
- By Vaccine Type
o Pre-Erythrocytic Vaccine
o Erythrocytic Vaccine
o Multi-Antigen Vaccine
- By Agent
o Plasmodium Falciparum
o Plasmodium Vivax
- By End Users
o Community Centers
o Others (retail pharmacies, online pharmacies, etc)
Market Drivers and Challenge
The malaria parasite has a very complex lifecycle and no vaccine is approved for human use. Increasing accessibility along with government support, artemisinin and P.falciparum resistance i.e. the most available anti malaria vaccine, rural population resides in malaria endemic areas and tourism from low incidence rate of malaria are identified as the most susceptible target population for malaria tends to drive the global malaria vaccine market. Regular monitoring, R&D programs on malaria and surveillance by various government programs will drive global malaria vaccines market growth during the forecast period.
Limited financial returns, little attraction for private commercial sectors and mosquito repellent products (patches, creams, coils, mats, liquids, etc.) tends to hinder the global malaria vaccine market.
Key Market Players
- Business Strategy
- Product Portfolio
- SWOT Analysis
Porter’s Five Force Model
Market Landscape: Competition and Beyond
Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem
Table of Content: Key Points
- Executive Summary
- Research Methodology
- Regional Opportunity Analysis on the basis of Competitors
- Global Malaria Vaccine Market Size (USD Billion) and Forecast Analysis, 2016-2024
- Market Dynamics: Growth Drivers, Restraints and Opportunities
5.1. Risk Factors
5.2. Regional Variations
5.3. Recent Trends and Developments
- Global Malaria Vaccine Market Segmentation
6.1. Malaria Vaccine Market By Vaccine Type (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.1. Adoption Rate (%) by Vaccine Type
6.1.2. Pre-Erythrocytic Vaccine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Get in touch: